Jazz Pharmaceuticals plc — Director's Dealing 2014

Mar 5, 2014

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Jazz Pharmaceuticals plc (JAZZ)
CIK: 0001232524
Period of Report: 2014-03-04

Reporting Person: Mulligan Seamus (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2014-03-04	Ordinary Shares	S	550000	$156.25	Disposed	1455555	Direct

Footnotes

F1: On March 4, 2014, the Reporting Person completed the sale of 550,000 ordinary shares pursuant to Rule 144.